[Dose-effect relationship of orally administered Pyritinol in the chronic organic brain syndrome (author's transl)].
161 patients with the chronic organic brain syndrome (average age 64 years) were treated with various oral doses of Pyritinol for various periods of time. Statistical analysis of the data by means of "Konfigurationsfrequenzanalyse" showed that the success rate of treatment increases significantly with increasing dose and duration of the treatment. This means that the recommended daily dose should be exceeded if - for example at the start of treatment and in severe cases or in hospitalized patients - there is no immediate clear improvement in the condition. From the point of view of method this study shows that a retrospective analysis of a group of patients treated in a clinic can also provide interesting results and appropriately supplement controlled studies.
D001925:Brain Damage, Chronic / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008875:Middle Aged; D011725:Pyridines / Q000627:therapeutic use*; D011746:Pyrithioxin / Q000627:therapeutic use*; D012189:Retrospective Studies
D011725:Pyridines; D011746:Pyrithioxin
Die Dosis-Wirkungs-Relation oraler Pyritinol-Gaben bei chronischem organischen Psychosyndrom.